Apoglyx logo


The American Peter Agre won the Nobel Prize in 2003 for the discovery of aquaporins, the body’s own water channels. However, it was Professor Per Kjellbom and his colleagues who identified how the water flow can be regulated. The researchers also found that aquaporin-inhibitors have the potential to be developed into a completely new type of therapy for reducing high blood sugar levels among diabetes patients.

It is hoped that a new diabetes medicine can be developed that will be administered in tablet form with fewer side effects than those of medicines currently on the market. The first target group is patients with reduced kidney function, for which there are currently no appropriate treatment options. 

ApoGlyx website





New diabetes medicine in tablet form with fewer side effects.

Founded by Per Kjellbom, Lund University, Søren Nielsen, Aalborg University and Michael Rützler, Aalborg University.

Portfolio company since 2008.


Portfolio Manager LU Holding:

christine [dot] widstrand [at] innovation [dot] lu [dot] se (Christine Widstrand), phone +46 70 928 63 78